What is Aldeyra Therapeutics, Inc.'s Market Cap?

Aldeyra Therapeutics, Inc.'s Market Cap is $90.5M, based on as-reported figures from SEC (XBRL) filings.

What is Aldeyra Therapeutics, Inc.'s Enterprise Value?

Aldeyra Therapeutics, Inc.'s Enterprise Value is $45.4M, based on as-reported figures from SEC (XBRL) filings.

What is Aldeyra Therapeutics, Inc.'s EV / EBITDA?

Aldeyra Therapeutics, Inc.'s EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.

What is Aldeyra Therapeutics, Inc.'s Net Income (TTM)?

Aldeyra Therapeutics, Inc.'s Net Income (TTM) is -$23.1M, based on as-reported figures from SEC (XBRL) filings.

What is Aldeyra Therapeutics, Inc.'s EBITDA?

Aldeyra Therapeutics, Inc.'s EBITDA is -$23.8M, based on as-reported figures from SEC (XBRL) filings.

What is Aldeyra Therapeutics, Inc.'s Diluted EPS (TTM)?

Aldeyra Therapeutics, Inc.'s Diluted EPS (TTM) is -0.38, based on as-reported figures from SEC (XBRL) filings.

What is Aldeyra Therapeutics, Inc.'s Net Debt?

Aldeyra Therapeutics, Inc.'s Net Debt is -$45.1M, based on as-reported figures from SEC (XBRL) filings.

Aldeyra Therapeutics, Inc. (ALDX) Financial Statements

Aldeyra Therapeutics, Inc.

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG0029H8ZG5

XNAS · usd

1.50▼ 0.04 (-2.60%)

As of 2026-09-09

Valuation

Market Cap

Enterprise Value

Trailing P/E—

Price / Sales—

EV / Revenue—

EV / EBITDA

Financial Highlights

Revenue (TTM)—

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin—

Net Debt

Trading Information

Previous Close1.54

Day's Range1.50 – 1.54

52-Week Range1.34 – 5.93

Volume543.9K

Avg Volume707.0K

Share Statistics

Shares Outstanding

Employees8

ExchangeXNAS

Listed2014-05-02

Share count as of August 4, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Aldeyra Therapeutics, Inc. (ALDX)

What is Aldeyra Therapeutics, Inc.'s Market Cap?: Aldeyra Therapeutics, Inc.'s Market Cap is $90.5M, based on as-reported figures from SEC (XBRL) filings.
What is Aldeyra Therapeutics, Inc.'s Enterprise Value?: Aldeyra Therapeutics, Inc.'s Enterprise Value is $45.4M, based on as-reported figures from SEC (XBRL) filings.
What is Aldeyra Therapeutics, Inc.'s EV / EBITDA?: Aldeyra Therapeutics, Inc.'s EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Aldeyra Therapeutics, Inc.'s Net Income (TTM)?: Aldeyra Therapeutics, Inc.'s Net Income (TTM) is -$23.1M, based on as-reported figures from SEC (XBRL) filings.
What is Aldeyra Therapeutics, Inc.'s EBITDA?: Aldeyra Therapeutics, Inc.'s EBITDA is -$23.8M, based on as-reported figures from SEC (XBRL) filings.
What is Aldeyra Therapeutics, Inc.'s Diluted EPS (TTM)?: Aldeyra Therapeutics, Inc.'s Diluted EPS (TTM) is -0.38, based on as-reported figures from SEC (XBRL) filings.
What is Aldeyra Therapeutics, Inc.'s Net Debt?: Aldeyra Therapeutics, Inc.'s Net Debt is -$45.1M, based on as-reported figures from SEC (XBRL) filings.